活血祛斑汤联合阿托伐他汀钙治疗痰瘀互结型颈动脉粥样硬化斑块临床研究
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R543.5

基金项目:


Clinical Study on Huoxue Quban Decoction Combined with Atorvastatin Calcium for Carotid Atherosclerosis Plaques of Binding of Phlegm and Stasis Type
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察活血祛斑汤联合阿托伐他汀钙治疗痰瘀互结型颈动脉粥样硬化斑块(CAAP) 的临床疗 效。方法:选择86例痰瘀互结型CAAP患者,以随机数字表法分为对照组和治疗组各43例。对照组给予阿托 伐他汀钙治疗,治疗组给予活血祛斑汤联合阿托伐他汀钙治疗。治疗6个月后,比较2组临床疗效、中医证候 评分、颈动脉内膜中层厚度(IMT)、斑块面积、血脂[三酰甘油(TG)、总胆固醇(TC)、高密度脂蛋白胆固 醇(HDL-C) 及低密度脂蛋白胆固醇(LDL-C) ]水平、超敏C-反应蛋白(hs-CRP) 水平及不良反应。结果: 治疗组总有效率95.35%,高于对照组79.07% (P<0.05)。治疗后,2组中医证候评分均较治疗前降低(P< 0.05),且治疗组低于对照组(P<0.05)。治疗后,2组IMT较治疗前变薄(P<0.05)、斑块面积均较治疗前减 小(P<0.05),且治疗组IMT值、斑块面积均小于对照组(P<0.05)。治疗后,2组TC、TG、LDL-C水平均较 治疗前降低(P<0.05),HDL-C 水平较治疗前升高(P<0.05);且治疗组TC、TG、LDL-C 水平低于对照 组(P<0.05),HDL-C水平高于对照组(P<0.05)。治疗后,2组hs-CRP水平较治疗前降低(P<0.05),且 治疗组hs-CRP水平低于对照组(P<0.05)。治疗期间,2组凝血功能、血尿常规及肝肾功能检查均无明显异 常,对照组患者出现肌痛1 例,停药后症状缓解。结论:活血祛斑汤联合阿托伐他汀钙治疗痰瘀互结型 CAAP效果确切,能进一步缓解症状体征,降低颈动脉内膜中层厚度,缩小斑块面积,调节血脂水平及减轻炎 症反应。

    Abstract:

    Abstract: Objective: To observe the clinical effect of Huoxue Quban Decoction combined with Atorvastatin Calcium Tablets for carotid atherosclerosis plaques (CAAP) of binding of phlegm and stasis type. Methods:A total of 86 CAAP patients of binding of phlegm and stasis type were randomly divided into the control group and the treatment group, with 43 cases in each group, using a random number table method. The control group was treated with Atorvastatin Calcium, and the treatment group was treated with Huoxue Quban Decoction combined with Atorvastatin Calcium. After six months of treatment, the clinical efficacy, traditional Chinese medicine (TCM) syndrome scores, carotid intima-media thickness (IMT),plaque areas,blood lipid levels [triglycerides (TG),total cholesterol (TC),high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C)], as well as the levels of highsensitivity C-reactive protein (hs-CRP) and adverse reactions were compared between the two groups. Results: The total effective rate was 95.35% in the treatment group, which was higher than that of 79.07% in the control group (P<0.05). After treatment,the TCM syndrome scores in the two groups were declined when compared with those before treatment,and the scores in the treatment group were lower than those in the control group (P<0.05). After treatment, the IMT in the two groups were thinner than those before treatment (P<0.05),and plaque areas in the two groups were reduced when compared with those before treatment (P<0.05),and the IMT value and plaque area in the treatment group were less than those in the control group (P<0.05). After treatment,the levels of TC,TG,and LDL-C in the two groups were declined when compared with those before treatment (P<0.05), and the levels of HDL-C were increased when compared with those before treatment (P<0.05);the levels of TC,TG,and LDL-C in the treatment group were lower than those in the control group (P<0.05), and the HDL-C level was higher than that in the control group (P<0.05). After treatment,the hs-CRP levels in both groups were decreased when compared with those before treatment (P<0.05),and the hs-CRP level in the treatment group was lower than that in the control group (P<0.05). During the treatment period, there were no significant abnormalities in coagulation function, blood and urine routine, and liver and kidney function tests in the two groups. One patient in the control group experienced muscle pain, and symptoms improved after discontinuation of medication. Conclusion: Huoxue Quban Decoction combined with Atorvastatin Calcium has a definite effect on the treatment of CAAP. It can further alleviate symptoms and signs, reduce the thickness of the carotid intima-media layer,reduce plaque area,regulate blood lipid levels,and alleviate inflammatory reactions.

    参考文献
    相似文献
    引证文献
引用本文

谭海军,武继涛,张耀光.活血祛斑汤联合阿托伐他汀钙治疗痰瘀互结型颈动脉粥样硬化斑块临床研究[J].新中医,2024,56(20):36-41

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2024-10-29
  • 出版日期:
文章二维码